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ABSTRACT  
 
The effects of conjugated linoleic acid and berberine supplementation on 
markers of oxidant status in broiler chickens 
Vincent Dartigue 
 
Selection for rapid growth in poultry can be linked to an exaggerated state of oxidative 
stress (reactive oxidative species, ROS). Reactive oxidative species are kept in balance by 
endogenous and exogenous antioxidants. Two compounds, conjugated linoleic acid (CLA) and 
berberine (BRB) a purified compound from plant root extract have been suggested to ameliorate 
antioxidant activity. A ten week study examined the effect of CLA and berberine supplementation 
on markers of oxidative stress in poultry. Broiler chickens (n=60) were equally divided into six 
groups; a control, a CLA group where half of the regular oil used in a standard was substituted for 
a CLA oil mixture of  cis-9 trans-11 and trans-10 cis-12 isomers, a berberine group (BRB) 
consisting of berberine supplementation (200mg/Kg feed), an allopurinol (ALLO) group  
(25mg/kg body weight), a CLA and allopurinol (CLA+ALLO) with the same dose as the CLA and 
allopurinol groups and a berberine and allopurinol group (BRB+ALLO) ( 200mg/Kg feed and 
25mg/kg body weight, respectively). The allopurinol was added to help induced an oxidative stress 
state. Body weight, plasma uric acid, plasma glucose, and relative gene expression of six 
endogenous liver antioxidants were measured during the course of the study. Neither berberine nor 
CLA had an effect on blood glucose concentration. The addition of allopurinol (ALLO) to the diet 
induced an oxidative stress state as measured by a significant reduction in plasma uric acid.  There 
was a 10-fold increase in the relative mRNA expression of superoxide dismutase 2 and 3 as well 
as glutathione 1 and 3 in CLA+ALLO and BRB+ALLO treatment groups. Notably, CLA increased 
the expression of uncoupling protein 34-fold compared to control while the addition of allopurinol 
blocked these changes. In contrast, there was a slight increase in the BRB+ALLO treatment. No 
significant changes were measured in blood glucose. In the case of plasma ceramides, there was 
significant decrease in concentration in the redox groups compared to controls.  Despite the 
increase in mRNA expression of the antioxidants genes, these results suggest that at the dosages 
administered, CLA and berberine were not effective in reversing the oxidative stress induced by 
allopurinol. Despite the increase in mRNA expression of the antioxidants genes, these results 
suggest that at the dosages administered, CLA and berberine were not effective in reversing the 
oxidative stress induced by allopurinol. 
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Literature Review 
Introduction  
 
Inflammation is a vital and crucial part of physiology and the immune system. It is characterized 
physiologically by redness, heat, soreness and rashes. At the molecular level, it is broader: from diapedesis 
to the chemical reactions and signaling responses involved in the process. The term inflammation can be 
further divided into an acute or chronic response. Acute inflammation can be defined as a short and 
pronounced response whereas it is sustained in the chronic response; which can be deleterious. Chronic 
inflammation has been linked to metabolic syndrome. And the term metabolic syndrome refers to a set of 
components such as hyperglycemia, hypertension and hypertriglyceridemia. In a high fat diet, excessive 
circulating fatty acids are not taken up by adipose tissue. These circulating fatty acids have signaling 
capabilities which have been shown to activate proinflammatory factors as part of the innate immune system 
which result in a state of inflammation. This component of the immune response utilizes reactive oxidative 
species to destroy foreign or dysfunctional molecules and place the subject in a control and temporary state 
f oxidative stress: the production of reactive oxidative species is increased, controlled and used toward a 
specific end (Esposito et al., 2004, Sutherland et al., 2004, Serhan et al., 2005, Monteiro et al., 2010). 
Reactive Oxidative Species  
 
Reactive oxidative species (ROS) are highly reactive oxygen based molecules. They include molecules 
such as superoxide anion (O2-), hydroxyl radical (OH-), hydrogen peroxide (H2O2), nitric oxide (NO), 
peroxynitrite (ONOO-) and singlet oxygen (1O2) (Carocho et al. 2013).  
From a metabolic point of view, ROS are generated by endogenous and exogenous pathways. 
Endogenous ROS are produced by electron leakage from the mitochondria or other organelles such as 
peroxisomes, and chloroplast in plants (Apel et al. 2004). Mitochondrial production of ROS starts as an 
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electron leak from the NADH dehydrogenase complex also known as Complex I  and the CoQ reductase 
complex, complex III of the electron transport chain (ETC), the latter having the highest rate of production 
as demonstrated by Qun et al. (2003). If there is a build-up of substrate in Complex I, the rate of electron 
transfer from ubiquinone to cytochrome C (Cyt C) in Complex III is reduced as Cyt C can only carry one 
electron at a time (Mujahid et al. 2009). As the build-up of substrate continues in Complex I, more electrons 
are presented to Complex III. Under normal conditions, the semiquinone would be re-reduced to ubiquinol 
by reacting with a proton present in the matrix. However, in the situation where there is an electron leak 
(before semiquinone can be reduced), the electron reacts with an oxygen molecule also present in the matrix 
creating a superoxide anion. (Albert et al. 2002) 
Another source of endogenous ROS production is through a process called “oxidative burst.” This 
process is mostly used in host immunity. The oxidative burst involves the generation of hydrogen peroxide 
and superoxide by nicotinamide adenine dinucleotide phosphate-oxidase enzyme (NADPH-oxidase, NOX). 
NOX is a family of transmembrane proteins involved in the reduction of oxygen to superoxide anion or 
hydrogen peroxide based on the homologue or type of activation triggered. The NOX family can be 
activated by several factors but its reduction capacity is limited by the amount of available NADPH, the 
reducing agent as well as oxygen, the oxidizing agent. (Apel et al. 2004). The production of hydrogen 
peroxide is thought to occur mostly when NOX is constitutively activated. Hydrogen peroxide, if left 
unchecked, can split and form hydroxyl radical.  
Exogenous ROS can also be produced by factors such as radiation and environmental factors such as 
chemical oxidants, hyperoxia toxins and chemotherapeutics (Bouzid et al. 2015). Once such 
chemotherapeutic is allopurinol. Allopurinol is a purine based analogue of hypoxanthine; it is a potent 
inhibitor of xanthine oxidase and thus is used primarily to treat gout in humans. It does so by inhibiting 
plasma uric acid (PUA) production, which itself is an antioxidant (Klandorf et al. 1999). It has been 
suggested that the long life span of birds compared to other animals of similar size can be associated to the 
concentration of circulating UA, which limits tissue damage (Holmes et al. 2001).  
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Reduction and oxidation (Redox) reactions are one of the major chemical pathway by which regulation 
of biological pathways occurs in cells (Ray et al. 2012). Although ROS generation is considered to be a 
byproduct of respiration it is highly regulated and kept in control by antioxidants. Because of the extensive 
regulation of ROS production it is not surprising that they can also be used in signaling pathways as second 
messengers involved in intracellular signaling (Martin et al. 2002, Foo et al. 2011). ROS messengers have 
unusual attributes and properties in the way they go about signaling. In conventional signaling, the substrate 
binds its receptor in a non-covalent way, which leads to a response.  Reactive oxidative species tend to 
create a covalent bond with their target resulting in a modification/structural alteration in the receptor. 
Situations where ROS are used as a second messenger, the target is expected to be modified with no 
unwanted and unforeseen impact/activity. After the oxidized receptor has generated its response, it’s 
degraded in order to prevent collateral damage. However, in the case of unplanned protein, lipid or DNA 
oxidation, there is no immediate regulation of these oxidized molecules, thus the structural alteration may 
lead to an undesired activity or cell response. For example, the alteration can lead to a change in cell state, 
leading to a non-homeostatic cell, which can be characterized by the overexpression of oncogenes, 
formation of mutagens and overall increase in inflammation (Martin et al. 2002, Wu et al. 2006, D’Autréaux 
et al. 2007, Pisoschi et al. 2015). In the case of an electron leak (and not as second messengers) ROS do 
not have specific targets, however, they exhibit an affinity for some types of molecules/patterns. For 
example, superoxide anion (O2-) has a high affinity for iron-sulfur clusters (Fe-S); O2- oxidizes the clusters 
at a high rate thus preventing their diffusion. All the O2- anions either oxidize a Fe-S cluster, or dismute to 
hydrogen peroxide, factors that limit its signaling capabilities. Hydrogen peroxide is much more versatile, 
it is uncharged compared to O2- , which allows it to diffuse across membranes and thus can activate a variety 
of second messengers (D’Autréaux et al. 2007, Veal et al. 2007). Further, hydrogen peroxide can elicit 
different responses dependent on its concentration. For example, Veal et al. (2007) suggested that in 
Schizosaccharomyces pombe different levels of H2O2 activate separate transcription responses. In another 
case, Sablina et al. (2005) reported that low levels of hydrogen peroxide triggers an antioxidant response 
whereas high levels induces apoptosis of the cell by increased expression of pro-oxidants. These limited 
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findings suggest that more research is needed on ROS signaling. However, in the botanical sciences it is 
widely accepted that ROS such as hydrogen peroxide and nitric oxide are key molecules involved in 
signaling pathways, both in biotic and abiotic factors but with a tight-regulation of antioxidants that limit 
the shift towards oxidative stress (Neil et al. 2001).  
Oxidative Stress 
 
Oxidative stress arises when the balance between oxidants (ROS) and antioxidants favors the formation 
of oxidants (Reuter et al. 2010, Settle et al. 2014). This imbalance can be characterized by a 
chronic/sustained state of inflammation. At the molecular level, oxidative stress causes DNA damage, lipid 
peroxidation and protein damage. The DNA, lipid or protein loses or gains an unwanted covalent bond 
formed by reaction with a ROS. High concentrations of damaged molecules can contribute to the 
inflammatory process by directing the cell away from the homeostatic state as seen in neurodegenerative 
diseases (Uttara et al., 2009). Another mechanism by which oxidative stress is linked to inflammation is 
the build-up of ROS, which activates some transcription factors that in turn leads to the production of 
inflammatory cytokines and chemokines. The localized presence of elevated levels of inflammatory 
cytokines and chemokines tend to attract macrophages that attack the host cells. Over a period of time, 
these factors contribute to chronic disease complications associated with cancer, diabetes or atherosclerosis 
for example (Reuter et al 2010). Thus, the concentration of ROS increases in the pancreatic beta cells there 
is an increase in macrophage infiltration that overtime causes the destruction of the beta cells effectively 
ceasing the production of insulin (Giongo et al. 2011, Sun et al. 2015).  
An increase in ROS production is usually the cause of inflammation, which if chronic is causes the 
disease itself such as inflammatory bowel disease or even aging. With this predetermined cascade of events; 
identifying oxidative stress markers resulting from ROS mediated oxidation represents a useful means of 
diagnosis. One classic method is the measurement of lipid peroxidation via thiobarbituric acid reactive 
substances, mainly malondialdehyde, which results from the decomposition of lipid peroxide 
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(Papastergiadis et al. 2012).  With the development and increased use of mass spectrometry, the greater 
sensitivity of the technique has permitted the detection of useful biomarkers.  
Ceramides and isoprostanes are 2 categories of lipids that have been linked with oxidative stress 
(Bikman et al. 2011). Ceramides are sphingolipids, composed of a sphingosine back-bone attached to a 
fatty acid. They are readily present in blood and in every tissue, being a major component of the cell wall. 
Their production occurs via 3 major pathways: de novo synthesis, sphingomyelin hydrolysis and the salvage 
pathway. The de novo synthesis pathway involves the addition of a serine amino acid to fatty acyl CoA by 
the enzyme serine palmitoyltransferase (SPT). The product of this reaction undergoes three further reactions 
before being an active ceramide.  The other two pathway of ceramide production are through ceramide 
recycling. Sphingomyelin hydrolysis is a pathway in which the phosphorylcholine group is hydrolyzed 
from the sphingomyelin by sphigomyelinase (SMase). The third means of producing ceramide is through 
the salvage pathway where sphingolipids are degraded in lysosome by acidic SMase to generate ceramides.  
An increase in circulating ceramides concentration has been positively correlated to stress stimuli and 
ROS generation, the primary path of production of ceramides being de novo synthesis, the second being 
the salvage pathway (Bikman et al. 2011). Other studies have shown that an increase in circulating ceramide 
concentration is associated with decrease insulin sensitivity, thus a decrease in nutrient uptake by the cell 
(Evan et al. 2002, Rico et al. 2016). Nutrient uptake and insulin insensitivity are linked by the ability of 
ceramide to down-regulate Protein kinase B/Akt. Ceramide can inhibit Akt, a serine threonine protein 
kinase, an enzyme that is involved in cell metabolism through the activation of protein phosphatase 2A 
(PP2A) which dephosphorylates Akt. Alternatively Akt activity is decreased by ceramides via Protein 
kinase C zeta intermediary (PKCζ) (Andrieu-Abadie et al. 2001, Summers et al. 2006, Bikman et al. 2011).  
Isoprostanes are endogenous prostaglandin-like (PG) compounds derived from arachidonic acid as a 
result of peroxidation with ROS independently of the cyclooxygenase enzyme pathway (COX) (Morrow et 
al. 1992, Liu et al. 2009). Isoprostanes are mainly isomers of prostaglandins F2α (PGF2α) that are biologically 
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active (Morrow et al 1992, Montuschi et al. 2004). Their measurement is a reliable indicator of oxidative 
stress. An increase in isoprostane concentrations is positively correlated with oxidative injury and is not 
affected by dietary lipids (Montuschi et al. 2004). Isoprostanes are equally present in both tissue and fluids 
and their presence in both tissues and fluid makes for a reliable indicator of oxidative stress (Bessard et al. 
2001, Montuschi et al. 2004). 
 Oxidative stress, as previously discussed, can be initiated by a variety of factors including a positive 
energy balance or heat stress, which includes an increase in body temperature and/or poor nutrient uptake 
which can be linked to an increase in metabolic activity. Birds are known to naturally have a higher rate of 
metabolism, body temperature, blood glucose, and double folded mitochondria, all of which would suggest 
an increase in production of ROS compared to mammals. However, birds tend to live longer than mammals 
of the same relative body size due to the production of various endogenous antioxidants including uric acid 
(Carro et al. 2010).    
Antioxidants 
 
Antioxidants (AOx) consist of a diverse range of molecules that limit the oxidation of substrates 
(Carocho et al. 2013, Oyewole et al. 2015). From proteins such as superoxide dismutase to simpler organic 
compounds, such as uric acid, they are all viewed as scavenger molecules with the ability to form a stable 
compound after being oxidized.  In normal conditions, AOx are there to maintain balance thus limiting the 
shift to oxidative stress status. Just like the oxidants, AOx can be classified as endogenous and exogenous 
(Settle et al. 2015, Pisoschi et al. 2015).  
Endogenous antioxidants are scavenging molecules/enzymes and include among them superoxide 
dismutase (SOD), catalase, glutathione peroxidase (GPX) and uric acid. Their primary purpose is to reduce 
ROS to a non-toxic state by functioning alone or working in concert (Larson et al. 1988). Enzymes such 
SOD have a metal base as a cofactor, in which is capable of accepting an electron. In the case of SOD, the 
metal bases are present in function of the location where SOD is synthesized; for example, iron (Fe), 
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cupper/zinc (Cu/Zn) bases are largely found in the cytosol whereas the manganese (Mn) base is mostly 
found within mitochondria (Blokhina et al. 2003). SOD accelerates the dismutation of superoxide radicals 
to the lesser toxic form, hydrogen peroxide, which is then converted to water and O2 by catalase (Halliwell 
et al. 1996, Blokhina et al. 2003).  
Another way to reduce oxidants is to donate the electrons in the form of protons.  As an endogenous 
scavenger, glutathione peroxidase (GPX) works in this fashion. The reaction usually involves two 
glutathiones: the thiol group from each glutathione donates the proton which results in the formation of a 
disulfide bridge, glutathione sulfide (GSSG). Glutathione sulfide is then recycled/reduced by NADPH via 
glutathione reductase (Fang et al. 2002).  
Plasma uric acid (UA) although not a protein is considered a potent antioxidant. UA is a product 
of purine degradation by way of xanthine oxidase metabolism of hypoxanthine and xanthine (Carro et al 
2010, Fabbrini et al 2014). Its antioxidant properties are associated with the enol form of uric acid.  After 
undergoing tautomerization, hydroxyl groups are produced which then react in the same mode of action as 
glutathione by donating protons (Figure. 1). The synthesis of uric acid can be reliably blocked via 
allopurinol administration, which offers a means to increase oxidative stress in broiler chickens (Klandorf 
et al 2001).  
Exogenous antioxidants on the other hand are non-protein based and are mostly found in fruits and 
vegetables. Pishoschi et al (2015) suggested that exogenous antioxidant can be divided into four major 
classes: two of the four are comprised of vitamin C and E and their variants, while the othe two are 
carotenoids and phenolic based compounds that include several subgroups.  In addition to these four major 
classes other compounds like minerals (selenium), and alkaloids compounds such as berberine may exert 
antioxidant properties (Baraboi et al., 1999, Li et al 2014).  
Berberine (Figure. 2) is derived from Coptidis Rhizoma and Phellodendri cortex (Kuo et al 2004). 
This compound is primarily used as an antidiarrheal in traditional Chinese medicine (Xu et al 2014).  In 
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addition, it possesses several known pharmaceutical properties which range from anti-cancer effects, to 
anti-diabetic and anti-inflammatory effects. It is not only considered to have direct antioxidant properties 
but can also elicit an increase in endogenous antioxidant production (Li et al 2014, Liu et al 2015, Xie et al 
2015). Berberine has been suggested to  increase the  activity of AMP activated protein kinase (AMPK) 
pathway and to decrease the mitogen activated protein kinase (MAPK) pathway as well as inhibit 
cyclooxygenase-2 and the necrosis factor-κB (NF-κB) pathway (Kuo et al. 2003, Lee et al. 2006, Li et al. 
2014, Fan et al. 2015). 
  Several factors have been suggested to limit the effectiveness of Berberine, among them is it rate 
of absorption. Berberine is not a readily soluble compound, in fact its solubility and thus its absorption is 
inversely related to its purity. Ma et al. (2016) suggested that Coptidis Rhizoma extract is more soluble and 
thus readily absorbed when compared to pure berberine. However, the extract is also accompanied by 
nanoparticles that offset its effectiveness.  
ROS neutralization by antioxidants, although effective, is not the only approach to keep them in 
balance. Another mechanism to target them is to decrease the initial production of ROS.  Hence, reducing 
the electron leak in the ETC, the site of production in the mitochondria by uncoupling protein (UCP), 
represents an alternative approach.   
Uncoupling protein 
 
Uncoupling protein (UCP) is a transmembrane protein transporter located in the inner membrane 
of the mitochondria (Abe et al. 2006). UCP is a member of a family of several homologues, which include 
UCP1, UCP2 and UCP3 in humans and are involved in thermogenesis and/or ROS balance by moving 
protons across the inner mitochondrial membrane, down their concentration gradient by fatty acid flippase 
activity. UCP are activated by free fatty acids (FFA) and inhibited by purine nucleotides in an allosteric 
manner (Echtay et al. 2001, Teulier et al. 2001, Diano et al. 2012, Berardi et al. 2014). Nucleotide binding 
occurs at the hydrophilic region with the phosphate group near the proline-kinks. The binding sites for FFA 
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are located on the outside of the protein, specifically in helix 1 and helix 6 of the transmembrane region. 
Fatty acyl chains are positioned in the hydrophobic region of helix 1 and 6 whereas the carboxylate head is 
located near the charged region close to the surface of the lipid bilayer. FFA binding to UCP results in a 
chemical change in the active site. Protons (H+) within the inter membrane space are translocated to the 
inner matrix in a FA-dependent manner with the carboxyl head of the fatty acid used as a proton acceptor. 
UCP effectively uncouples respiration (ETC) from oxidative phosphorylation. It selectively 
decreases the gradient of protons required by complex V to drive ADP phosphorylation in addition to 
increasing the proton gradient in the mitochondrial matrix which decreases the probability of the electron 
on semiquinone from reacting with O2 and creating a superoxide anion (Criscuolo et al. 2005). Electrons 
are transported as a proton via NADH to complex I and III at which point they reduce ubiquinone (Q) to 
ubiquinol (QH2). Ubiquinol cycles through complex III which presents the electron to cytochrome C (Cyt 
C) effectively reducing it. Cyt C, however, can only transport one electron at a time, so ubiquinol is partially 
reduced to semiquinone. At this point the semiquinone, which carries the electron has two possible paths. 
One possibility is that the electron is “leaked” and reacts with O2, which functions as an electron acceptor, 
leading to a superoxide anion thus creating reactive oxidative species. A second possibility is that before 
the electron is leaked; semiquinone is re-reduced to ubiquinol by reacting with a proton present in the 
mitochondrial matrix that was moved from the inter membrane space of the mitochondria to the matrix by 
UCP. The ubiquinol can then, undergo a second cycle and present the second electron to Cyt C and proceed 
through the ETC (Genova et al. 2014, Baniulis et al. 2016).   
 UCP1 is mostly found in brown adipose tissue (BAT) with significant role in thermogenesis. A 
proton leak in this homologue has been associated with the generation of heat by uncoupling oxidative 
phosphorylation from the mitochondrial ETC (Krauss et al. 2005). This process allows energy to be released 
as heat. The UCP 2 and UCP3 homologues have been suggested to be involved in a reduction in ROS by 
the previously described mechanism. UCP 2 is expressed in several tissues whereas UCP 3 is limited to 
skeletal muscle and BAT and WAT (Shabalina et al 2013).  
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Overall regulation of the UCP homologues has been linked to the sympathetic nervous system. In 
situations where there is a need for an increase in uncoupling activity, β-adrenergic receptors are activated 
by catecholamines. This activation leads to an increase in the uptake of fuels by the cells expressing UCP. 
The increase in fuels (primarily glucose) leads to an increase production of NADH and FADH2, which is 
used to increase the UCP activity.  
The thermogenic capacity of UCP makes it a potential target when investigating possible factors in 
the treatment of obesity. Different methodologies to treat obesity include the approach of using UCP’s 
thermogenic properties. However, obesity can be accompanied by diabetes, which is the absence or 
inefficient action of insulin. Herein lies the double edge source of UCP.  Krauss et al. (2005) suggested that 
UCP can exacerbate insulin production based on the ratio ADP/ATP. As glucose is oxidized, NADH and 
FADH2 feed into the ETC which is coupled with oxidative phosphorylation. The increase ATP production 
in turn leads to the production/release of insulin. However, when oxidative phosphorylation is uncoupled 
from the ETC by UCP, the concentration of ATP produced does not truly represent the state of the host and 
so the amount insulin produced is not reflective of the actual energy balance. Thus an insufficient amount 
of blood glucose is taken up from circulation which results in a prolonged state of insulin, hyper-secretion 
by the β-cells. Ultimately this situation may result in insulin being processed and presented/ treated as a 
self-antigen which lead to lymphocytic infiltration of the beta cells.   
Avian UCP closely resembles that of the mammalian (approximately 70%) UCP2 and UCP3 in its 
affinity and its activation by free fatty acids. Amongst the possible fatty acids available that activate UCP; 
it has been suggested that conjugated linoleic acid is a likely candidate (Abe et al., 2006, Mujahid et al., 
20006).  
Conjugated linoleic acid 
 
 Conjugated linoleic acid (CLA) refers to a group of fatty acids that are 18 carbon long; the term 
conjugate is used to describe a mixture of 28 geometric isomers of linoleic acid (Yang et al. 2015). The 
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primary source of CLA is from dairy products. Dietary linoleic acid are biohydrogenated by the ruminants’ 
rumen microbiota, which generates the various isomers. Some of the isomers may than be incorporated into 
the animal’s fat or milk. Chemicals synthesis of CLA from safflower and sunflower oils has been 
commercialized. Of the 28 conjugated systems, cis-9 trans-11 and trans-10 cis-12 have been shown to be 
the forms capable of exerting metabolic effects. However, selection for the two isomers that affect 
metabolism is difficult as a mix of conjugated product is normally obtained (Takashi et al. 2002).  
Of the two isomers having a metabolic effect, trans-10 cis-12 possesses lipolytic activity; whereas 
the cis-9 trans-11 isomer is anabolic and anti-inflammatory. However, both isomers do possess anti-
carcinogenic properties. Although cis-9 trans-11 is correlated with anti-inflammatory actions; both isomes 
possesses some anti-inflammatory properties. It has been suggested that CLA replaces linoleic and 
arachidonic acid, consequently reducing the activity of COX and LOX as mediators of inflammation. The 
cis-9 trans-11 isomer of CLA has been suggested to diminish the expression of both interleukin 6 and 1β, 
as well as the tumor necrosis factor alpha (Radmark et al. 2014; Yang et al. 2015).  
Additional studies have investigated CLA’s interaction with peroxisome proliferator activated 
receptor (PPAR) and UCP. PPAR a family of transcription factors involved in anabolism that can be 
activated by polyunsaturated fatty acids.  This family is composed of PPAR α, β, γ1 and γ2. (Ramiah et al. 
2014, Viladomiu et al. 2015).  The PPAR family are involved in processes such as triglyceride synthesis 
and fatty acid uptake by down regulating genes such as lipoprotein lipase and fatty acid synthase as well as 
activating fatty acid oxidation. The different homologue have different properties, with PPARα involved in 
catabolism, fatty acid oxidation, lipoprotein transport and mostly active in the fasting state. PPARγ on the 
other hand is expressed in a fed state and is characterized by lipogenesis and fatty acid transport. PPARβ is 
a modulator of PPARγ (Kersten et al., 2000). The PPAR family also possesses anti-inflammatory properties 
through various pathway, for example, interaction with NF-κB. Studies by Chen et al. (2014) and Lian et 
al. (2015) found that supplementing PUFAs in the diet was correlated with a decrease in markers of 
inflammation such interleukin and cytokines but also in NF-κB. It was Hou et al. (2012) who elucidated 
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the mechanism showing that the ubiquitination of NF-κB by PPAR, effectively tags it for degradation 
(Marion-Lettellier et al. 2016). 
Uncoupling protein 1 in humans plays a role in fatty acid oxidation and heat production. CLA has 
been linked with an increase in the activity and expression of UCP (Yang et al. 2015, Baraldi et al. 2016). 
As it uncouples oxidative phosphorylation, the energy is dissipated as heat. Because ATP concentrations 
are not indicative of the energy level, more substrate is sent to the ETC in order to reinstate/restore 
homeostasis. One of the sources of substrate are the fat reserves; hence the reduction of body fat associated 
with UCP (Yang et al. 2015).  
Conclusion and Justification  
 
Selection of fast growing chicken in the poultry industry has led to the generation of broiler 
chickens defined by an increased metabolism, capable of generating market standards in an average of six 
weeks. Heat stress which has been linked to oxidative stress, defined by increased reactive oxidative 
species, is a significant concern as it impacts production and the overall health of the bird (Akbarian et al. 
2016; Fellenberg et al. 2006). The use of allopurinol in broiler chicken production has previously been 
shown to mimic the heat stress and by association the oxidative stress state with the added possibility of 
controlling the severity of the stress (Klandorf et al. 2001, Simoyi et al. 2002, and Settle et al. 2015). With 
this background and knowledge, we posited that the use of compounds, such conjugated linoleic acid and 
berberine would decrease reactive oxidative species, and thus partially ameliorate the oxidative stress state 
induced by allopurinol (Dartigue et al. submitted).  
 
Objective  
To determine the effect of CLA and berberine supplementation on markers of oxidant status in 
broiler chickens 
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Figures 
 
Figure 1. Uric acid keto-enol tautomerization (adapted from Nimse, 2015) 
 
Figure 2. Berberine and its metabolite (adapted from https://examine.com/supplements/berberine/) 
 
 
Figure 3. Linoleic and conjugated linoleic acid (https://authoritynutrition.com/conjugated-linoleic-acid/) 
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Chapter 1 
 
Abstract 
 
Selection for rapid growth in poultry can be linked to an exaggerated state of oxidative stress (reactive 
oxidative species, ROS). Reactive oxidative species are kept in balance by endogenous and exogenous 
antioxidants. Two compounds, conjugated linoleic acid (CLA) and berberine (BRB) a purified compound 
from plant root extract have been suggested to ameliorate antioxidant activity. A ten week study examined 
the effect of CLA and berberine supplementation on markers of oxidative stress in poultry. Broiler chickens 
(n=60) were equally divided into six groups; a control, a CLA group where half of the regular oil used in a 
standard was substituted for a CLA oil mixture of  cis-9 trans-11 and trans-10 cis-12 isomers, a berberine 
group (BRB) consisting of berberine supplementation (200mg/Kg feed), an allopurinol (ALLO) group  
(25mg/kg body weight), a CLA and allopurinol (CLA+ALLO) with the same dose as the CLA and 
allopurinol groups and a berberine and allopurinol group (BRB+ALLO) ( 200mg/Kg feed and 25mg/kg 
body weight, respectively). The allopurinol was added to help induced an oxidative stress state. Body 
weight, plasma uric acid, plasma glucose, and relative gene expression of six endogenous liver antioxidants 
were measured during the course of the study. Neither berberine nor CLA had an effect on blood glucose 
concentration. The addition of allopurinol (ALLO) to the diet induced an oxidative stress state as measured 
by a significant reduction in plasma uric acid.  There was a 10-fold increase in the relative mRNA 
expression of superoxide dismutase 2 and 3 as well as glutathione 1 and 3 in CLA+ALLO and BRB+ALLO 
treatment groups. Notably, CLA increased the expression of uncoupling protein 34-fold compared to 
control while the addition of allopurinol blocked these changes. In contrast, there was a slight increase in 
the BRB+ALLO treatment. No significant changes were measured in blood glucose. Despite the increase 
in mRNA expression of the antioxidants genes, these results suggest that at the dosages administered, CLA 
and berberine were not effective in reversing the oxidative stress induced by allopurinol.  
Key words: allopurinol, antioxidants, broiler, ceramide, oxidative stress,  
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Introduction 
 
Inflammation is of significant concern in the poultry industry, it impacts production worldwide and 
the overall health of the chicken. Inflammation can arise from both environmental and internal factors, the 
former can be usually traced back to an increase in ambient temperature. The latter has a broader range of 
origin from species to gender and metabolism. Both environmental and internal factors are characterized 
by an increase in oxidative stress (Cerruti et al., 1993, Federico et al., 2007, Fellenber et al., 2006). 
Oxidative stress results from an imbalance between reactive oxidative species (ROS), which are highly 
reactive oxygen base molecules, and antioxidants (AOx). A major source ROS is the electron transport 
chain (ETC) (Chen et al., 2012, Murphy et al., 2009) and in an imbalance state they represent a danger to 
aerobic organisms because of their high reactivity and tendency to form covalent bonds with lipids, proteins 
and DNA (Martin et al., 2002, Wu et al., 2006, D’Autréaux et al., 2007). Any structural alterations in 
molecules can lead to a change in cell state, distancing itself from cell homoeostasis, which can be 
characterized by overexpression of oncogenes, formation of mutagens, and overall inflammation (Pisoschi 
et al., 2015).  
Birds in general have higher level of plasma glucose than mammals which simulates/mimics a 
constant state of hyperglycemia. They, however, do not exhibit any noticeable side effects observed in 
mammals with similar concentrations.  This is prevented by an elevated levels of plasma uric acid. Plasma 
uric acid is a potent Aox for circulating ROS in species lacking uricase. Previous studies in poultry have 
demonstrated that allopurinol supplementation reduces plasma uric acid concentrations thus establishing a 
controllable oxidative stress model (Simoyi et al., 2002). In a normal state, ROS generation is balanced by 
antioxidants and other molecules having AOx like properties, which target and neutralize the oxidative 
species. Antioxidants can be characterized as endogenous or exogenous. The main families of endogenous 
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Aox are the superoxide dismutase and the glutathione family while the exogenous ones are mostly 
characterized by the presence of a phenol group (Pisoschi et al., 2015, Larson et al., 1987).  
Berberine, an exogenous Aox isolated from plant root extract, has been used in traditional Chinese 
herbal medicine. This compound is a quaternary ammonium salt that possesses several benzene rings and 
methoxy functional groups, which allows the electron to circulate within the conjugated double bond 
system. In addition to increasing the activity of endogenous antioxidants, berberine is reputed to possess 
anti-diabetic, anti-inflammatory and anti-carcinogenic properties (Meeran et al., 2008, Li et al., 2014, Liu 
et al 2015, Xie et al., 2015).  Neutralization of ROS may also be achieved by activation uncoupling protein 
(UCP). Uncoupling protein is a member of the family of the transmembrane proteins located in the inner 
membrane of the mitochondria homologues involved in thermogenesis and ROS balance. Its main mode of 
action is to uncouple respiration (ETC) from oxidative phosphorylation and it does so by moving protons 
from the inner mitochondrial membrane space into the matrix (Teulier et al., 2001; Abe et al., 2006). This 
action increases the probability of any pair of protons of reacting with superoxide radicals, thereby, creating 
metabolic water from catalase or glutathione peroxidase. Berardi et al. (2014) has suggested that UCP can 
be activated by the binding of fatty acid (C14 to C18) to the receptor whereas purine nucleotides act as 
allosteric inhibitors. For example, trans-10 cis-12 conjugated linoleic acid (CLA) has been shown to affect 
energy balance through up-regulation of UCP activity (Abe et al., 2006, Mollica et al., 2014, Viladomiu et 
al., 2015, Yang et al., 2015). CLA refers to a collective of fatty acids, each 18 carbons long. The primary 
source of CLA is from dairy products and beef, lamb and goat fat by hydrogenation of dietary linoleic acid 
and stearic acid. Of the 28 conjugated isomers, the cis-9 trans-11 and trans-10 cis-12 are produced in the 
greatest quantity and were shown to have the most prominent metabolic effects. The purpose of this study 
was to determine if the addition of berberine or CLA to the diet of broiler chicken could reverse the 
induction of an oxidative stress state induced by allopurinol. We hypothesized that the addition of the two 
compounds should increase the endogenous antioxidants possibly reverting the redox state induced by the 
help of the allopurinol. 
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Material and Methods 
All procedures and experiments were approved by West Virginia University’s Institution Animal Care and 
Use Committee (ACUC #15-0301.1).  
Experimental Design 
 Three study were conducted, two preliminaries and the main study. The two preliminary (prelim) 
studies were conducted using forty five and seventy mixed sex day old Cobb/Cobb 500 broiler chicks, 
respectively. In the main study, sixty mixed sex day old Cobb/Cobb 500 broiler chicks were used. All chicks 
were obtained from Pilgrim’s Pride, Moorefield, WV. Chicks were housed within pens and maintained 
under a twelve hour light-dark cycle with temperature set at 27°C.  For the first two days after hatch, chicks 
were kept in the same pen with a heating lamp. On the third day, chicks were divided in two pens until they 
reached one week of age, at which time they were tagged with leg bands and divided into six pens based 
on weight. The chicks were kept on a starter diet for the first four weeks. At week five of the study, the 
broiler chickens were started on different treatments (see Table 1). 
Preliminary study 1 treatments 
The first preliminary study lasted for a total of nine weeks was composed of 4 groups. The 4 treatments 
were composed of a control diet, a berberine diet (BRB) supplemented with berberine (100mg/kg of feed) 
(Li et al 2014), a conjugated linoleic (CLA) diet as explained in the main study. The last diet was a 
combination of berberine and CLA (BRB+CLA) which mirrored the BRB and CLA treatments. For the 
second preliminary study, the design registered four groups of eight chicks with replicates. 
Preliminary study 2 treatments 
For the second preliminary study, the design registered four groups of eight chicks with replicates and also 
lasted nine weeks. The second preliminary study 2 was composed of a control diet, a berberine diet (BRB) 
supplemented with berberine (200mg/kg of feed), an allopurinol diet (ALLO) given at a dose of 25mg/kg 
body weight (Klandorf et al., 2001) and the last diet was a combination of berberine and allopurinol 
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(BRB+ALLO) which mirrored the BRB treatments with the addition of allopurinol (25mg/kg of body 
weight) for the last week of the study. Groups four five through eight were treated with allopurinol to help 
induce a redox state (Settle et al., 2012). Weights were recorded weekly over the five weeks of experimental 
period. Berberine (prelim 1: chloride, purity >99%, prelim 2: chloride hydrate, purity >99%), the CLA, and 
the allopurinol for the respective studies were purchased as stated in the main study. 
Main Study treatments 
The main study lasted for ten weeks and was composed of a control group, a CLA group in which half of 
the regular oil used in the normal diet was substituted for a mixture of 50/50 cis-9 trans-11 and trans-10 
cis-12 isomers CLA oil (1.1% CLA oil diet) (Ramiah et al 2014). Group 3 (BRB) was supplemented with 
berberine (200mg/kg of feed) (Li et al 2014), group 4 (ALLO) was given allopurinol (25mg/kg of body 
weight) (Klandorf et al 2001), group 5 (CLA+ALLO) and 6 (BRB+ALLO) mirrored the CLA and BRB 
treatments with the addition of allopurinol (25mg/kg of body weight) for the last two weeks of the study. 
Groups four five and six were treated with allopurinol to help induce a redox state (Settle et al 2012). 
Weights were recorded weekly over the six week experimental period. Berberine (chloride hydrate, purity 
>99%) and Allopurinol were purchased from Sigma-Aldrich (Saint Louis, MO, USA). The CLA was 
purchased commercially (Vitamorph Labs, Highland, IN, USA) as 1200 mg capsules. Food and water were 
provided ad libitum.  
Sampling procedure 
After two weeks on treatment, in all three studies blood samples (4ml) were obtained from six birds per 
pen from the brachial (wing) vein. Each sample was transferred to a heparinized tube and immediately 
placed on ice.  The same birds were sampled for the next three bleedings: for a total of four bleedings.  Once 
the samples were collected they were centrifuged at 2000 rpm for 20 minutes at 4°C to collect plasma. They 
were stored at -20° C, pending analysis. On the last day of the study, the birds were euthanized and a sample 
of liver (~1g) was snap frozen in liquid nitrogen until stored in a -80°C freezer for further analysis.   
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Sample analysis  
Plasma samples in the -20°C were used for measurement of plasma glucose and plasma uric acid. 
Plasma glucose was measured using amperometric measurement of hydrogen peroxide (H2O2) on a 
platinum electrode (YSI 2700 Biochemistry analyzer) (Hall et al., 1998, Klandorf et al., 2001). Plasma uric 
acid (PUA) was measured using Infinity™ Uric Acid Liquid Stable Reagent assay from Thermo Scientific 
(Waltham, MA, USA; Klandorf et al 2001).  
Liver samples (75-100 mg) were used to study the relative mRNA expression of six antioxidant related 
genes in the superoxide dismutase (SOD) family, glutathione (GPX) family and uncoupling protein (UCP) 
family. A Trizol-Reagent (Invitrogen™, Carlsbad, CA) based method was used to extract and isolate total 
RNA. The isolated RNA was resuspended in nuclease free water and treated with DNase (Ambion®, 
Thermo Scientific Waltham, MA, USA).  Four microliters of DNase treated RNA were reverse transcribed 
to cDNA utilizing an iScript™ cDNA synthesis kit from Bio-Rad (Hercules, CA). A SYBR® Green Master 
Mix kit (Bio-Rad, Hercules, CA) method was used on a BIORAD CFX96 Real Time System (C1000 Touch 
Thermal cycler) to quantify the expression of SOD1, SOD2, SOD3, GPX1, GPX3 and avUCP using 
designed primers. The gene sequences were obtained from the ncbi data base 
(https://www.ncbi.nlm.nih.gov) and designed using the Primer3 Input (version 4.0 
http://bioinfo.ut.ee/primer3-0.4.0/primer3/) (see Table 2). Results of real time PCR were normalized to the 
housekeeping gene GAPDH. Calculation and analysis of mRNA expression was performed using the 
efficiency corrected delta-delta Ct method (Barnes et al., 2012).  
Sampling procedure and sample analysis  
The sampling procedure again followed the main study with the exception of the addition of the 
resolving medium (Mono-Poly, MP biomedicals, LLC Solon, Ohio) was added, in a 1:1 ratio, to separate 
the leukocytes in both preliminary studies. Half of the sample were transferred to a new tube where a 
resolving medium (Mono-Poly, MP biomedicals, LLC Solon, Ohio) was added, in a 1:1 ratio, to separate 
the leukocytes. All the samples were centrifuged at 2000 rpm for 20 minutes at 4°C to collect plasma and 
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leukocytes. The plasma samples were stored at -20° C, pending analysis. The leukocytes were transferred 
to micro centrifuge tube and place on ice for immediate analysis. No liver samples were taken.  
 The analysis was the same with the exception of oxidative stress measurement.  Oxidative stress 
was measured using L-012 (8-Amino-5-chloro-7-phenylpyrido[3,4-d]pyridazine-1,4-(2H,3H)dione 
Sodium Salt) base chemiluminescence techniques (Van Dyke et al 1987, Klandorf et al 2001). The 
leukocytes were activated using a phorbol 12-myristate 13-acetate (pma) (Sigma Saint Louis, MO, USA). 
Statistical analysis  
In preliminary studies, the effects of experimental treatments on bodyweight, plasma uric acid, 
plasma glucose and oxidative stress measurements were analyzed using ANOVA with treatment as main 
effect. Tukey’s multiple comparison test was used for specific pair wise comparison. 
In the main study, the effects of experimental treatments on bodyweight, plasma uric acid, and 
plasma glucose and gene expression were analyzed using ANOVA with treatment as main effect. Tukey’s 
multiple comparison test was used for specific pair wise comparison. Statistical analysis for gene expression 
was done on ΔCt, however, the ΔΔCT measurement were used in the figures.  The values presented are the 
LSM+SE. Statistical analysis was done using JMP program (SAS Institute Inc., Cary NC). Statistical 
significance was set at P < 0.05. 
Results 
Preliminary Studies 
 In short, in the first preliminary study there was a significant difference between control and the 
BRB+CLA group body weight, 2.45 kg and 1.95 kg respectively. In the second preliminary study, there no 
differences to report. End point plasma uric acid analysis revealed in the first prelim a significant decrease 
PUA in the BRB and BRB+CLA groups compared to controls, 0.30, 0.36 and 0.48 mM, respectively; in 
the second, we observed a significant decrease in all treatments compared to controls. The control had a 
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PUA concentration of 0.44 mM whereas the other 3 treatments averaged around 0.35mM. In reactive 
oxidative species analysis, BRB group was significantly lower when compared to control.   
 Main study  
There was no significant differences in body weight (BW) gain between the treatments. For plasma 
uric acid analysis, there was a significant (P < 0.05) decrease in plasma uric acid concentrations towards 
the end of the study in groups administered allopurinol compared to the control (Fig 1). The decrease was 
more pronounced (P < 0.05) in the CLA+ALLO and BRB+ALLO groups, 0.17mM and 0.16mM 
respectively, compared to both ALLO (0.27mM) and controls ( 0.43mM). Neither berberine nor CLA had 
a measurable effect on plasma glucose concentrations (Table 2). In the BRB group, there was a significant 
decrease in liver/bodyweight ratio compared to controls (Fig 2). Allopurinol administration in ALLO, 
CLA+ALLO and BRB+ALLO groups increased (P < 0.05) the liver/BW ratio as compared to the controls, 
Fig 2. However, CLA+ALLO and BRB+ALLO led to a numerical decrease in liver/bw ratio compared to 
ALLO group.   
The relative expression of superoxide dismutase (SOD) 1 through 3, uncoupling protein (UCP) and 
glutathione (GPX) 1 and 3 are shown in Fig 3. The genes were chosen based on their location and their 
targets.  SOD 1 and 3 uses Cu/Zn as electron acceptors and were expressed in the outer mitochondrial 
membrane and in the cytoplasm, respectively. SOD2 has manganese as an electron acceptor and is located 
in the mitochondrial matrix.  GPX 1 and 3 differed base on their location, intracellular and plasma soluble 
respectively. Only one homologue of UCP was studied.  Control unit were expresses as arbitrary units and 
set as 1. In the non-redox state, CLA led to a 4 fold increase in SOD1, whereas BRB slightly decrease 
SOD1 expression below controls (Fig 3, A). The ALLO group increased SOD1 expression by 3 fold, which 
was not significant. The redox state, however, caused by allopurinol led to a 6 and 12 fold increase (P < 
0.05) in both CLA+ALLO and BRB+ALLO.  
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SOD2 expression across treatments was comparable to the changes observed in SOD1 (Fig 3, B). 
In the non-redox state, CLA increased SOD2 six fold, whereas BRB increased the expression two fold. 
However, SOD2 expression decreased in ALLO group in contrast to the increase observed in SOD1.  CLA 
and BRB, when exposed to allopurinol led to an increase in expression of SOD2. CLA+ALLO also 
significantly increased SOD2 relative expression by 7 and BRB+ALLO by 16 fold (P < 0.05). In contrast 
to SOD1 and SOD2, SOD3 expression in CLA, BRB and ALLO groups were not significantly different 
compared to the controls (Fig 3, C). The redox state, however, increased expression of SOD3 in 
CLA+ALLO and BRB+ALLO, at 10 and 9 fold, respectively. 
A marked increase in uncoupling protein (UCP3) expression occurred in response to the CLA 
treatment (34 fold increase) whereas BRB marginally affected UCP expression (3 fold increase) when 
compared to controls (Fig 3, D). UCP3 expression decreased in the ALLO group as compared to control. 
In contrast to CLA, CLA+ALLO only increased UCP expression 4 fold whereas there was a 10 fold increase 
in UCP3 expression in the BRB+ALLO group. 
Glutathione1 (GPX1) expression was similar to that observed in the SOD3 group (Fig 3, E). In the 
non-redox state, CLA and BRB did not undergo significant changes in expression. In the redox state, ALLO 
did not change the expression of GPX1, whereas CLA+ALLO and BRB+ALLO treatments led to a 9 and 
10 fold increase (P < 0.05), respectively. Glutathione 3 (GPX3) expression closely resembled that of SOD 
2 in both the non-redox and redox state (Fig 3, F). There was a small increase in GPX3 expression in the 
CLA and BRB groups, as well as in the allopurinol treated birds. CLA+ALLO and BRB+ALLO modulation 
were pronounced with increase expression of 5 and 11 fold, respectively (P < 0.05).  
Discussion and Conclusions 
Plasma uric acid is a potent antioxidant in birds and its inhibition has been linked to an increase in 
ROS production in chicken (Settle et al., 2012 & 2015). Previous studies have established that allopurinol 
is a potent inhibitor of plasma uric acid in chicken which leads to a redox state in the chicken (Klandorf et 
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al., 2001, Simoyi et al., 2002). The degree or severity of the redox state can be varied depending on the 
dosage of allopurinol administered, resulting in a somewhat controllable model of oxidative stress for redox 
study. Making use of this model, we set out to test to determine if berberine and/or CLA could restore the 
bird to its pre-redox state caused by the administration of allopurinol.  
One week after administration allopurinol, PUA declined in all treated groups. By week 10, the 
ALLO group had a level of plasma uric acid of 0.27mM compared to the control, 0.40 mM. However, this 
decline was unexpectedly more pronounced in both the CLA+ALLO and BRB+ ALLO groups as they 
reached levels of 0.17 and 0.16mM respectively (P < 0.05). Kong et al (2004) suggest that berberine may 
have an inhibitory effect on xanthine oxidase; if so this would explains the negative synergistic effect on 
the plasma uric acid level.  
CLA is known to increase the activity and expression of UCP (Takahashi et al., 2002) whereas 
berberine is suggested to reduce blood glucose concentration in Type 2 diabetes by increasing insulin 
sensitivity (Xing et al., 2011) as well as enhance the expression of endogenous antioxidants such as SOD 
(Li et al., 2014). UCP is a transmembrane protein with its active site exhibiting flippase activity to move 
protons. The accumulation of protons in the matrix increases the probability that a proton interacts with an 
electron as they cycle through complex III and IV. As the animal transitions from a normal to redox state, 
there should be an increase in antioxidants to neutralize the ROS and potentially dampen the effect of the 
shift. With this basic premise, the addition of these compounds was expected to increase the expression of 
antioxidant genes.  To test this hypothesis, we measured the mRNA expression of six endogenous 
antioxidants genes. Berberine administration led to an increase in the relative expression of SOD 1, 2 and 
3 by 13, 16 and 8 fold respectively. These compounds also improved mRNA expression of UCP, glutathione 
1 and 3, by a 10 fold change in both UCP and GPX1 and an 11 fold change in GPX3. Although, CLA was 
hypothesized to affect UCP, it also increased the relative expression of other endogenous antioxidants, 
albeit less pronounced. Comparable results were reported by Cantwell et al. (1999) in human cell line 
exposed to cow milk containing CLA.  
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Reactive oxyegen are kept in balance by antioxidants. The superoxide dismutase (SOD) family and 
glutathione are among the principal endogenous antioxidants. SOD catalyzes superoxide to hydrogen 
peroxide, which is then degraded to in water and oxygen by glutathione (Halliwell et al., 1996). Overall, 
for the SOD family, CLA led to a 7, 6 and 8 fold increase in SOD 1, 2 and 3, respectively. Cellular 
glutathione’s expression increased by 9 fold whereas the increase in extracellular glutathione was 5 fold. 
However, the addition of CLA to allopurinol did not result in further increase in UPC expression. 
Allopurinol is a purine analogue which may have inactivated UCP, which is down-regulated by purines. It 
is possible that allopurinol also masked the effect of CLA on UCP. This would explain the 3 fold increase 
in the redox state in contrast to the 34 fold increase in UCP expression without allopurinol. Furthermore 
CLA modulation of UCP expression could be an additional means to maintain ROS balance 
 An increase in ROS has been linked to liver inflammation due to the recruitment of inflammatory 
cells. ROS signaling leads to leukocytes infiltration which in turn leads to additional ROS production 
(Greenhalgh et al., 2015). In the current study, we measured an increase in liver size in the ALLO group as 
well as an increase in the liver to BW ratio as compared to controls. The addition of the BRB and CLA to 
the allopurinol treated birds was able to numerically decrease liver weight but not back to control levels. 
These results are in agreement with Hwang et al. (2002) who observed in rats that berberine decreased ROS 
production and the incidence of liver lesions by an increase glutathione production. The results suggest that 
at the dosages used in this study CLA and berberine were not able to completely restore to a non-redox 
state in birds administered allopurinol.   
The data gathered in the preliminary studies were used to draw conclusion in parallel with our main 
study. The use of the allopurinol redox model in birds to study the effect of CLA and berberine on markers 
of oxidative stress was not conclusive. The liver to BW ratio suggested that the addition of CLA and 
berberine were able to partly reduce the inflammation of the liver but not to control levels.  A further 
reduction in plasma uric acid by these two compounds to allopurinol fed birds was not anticipated, which 
suggest that additional ROS may have been produced. CLA and berberine were able to increase the relative 
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mRNA expression of the selected endogenous antioxidant genes but without measurement of the gene 
product, we do not know if these changes have been translated/expressed. Finally, at the dosage of 
allopurinol used we were not able to completely revert the redox state. We conclude that the allopurinol 
model can be used to measure the ability of alternative compounds to ameliorate the induced oxidative 
stress.  
Figures 
Figure 1. Change in plasma uric acid (mM) over the course of the last four weeks of treatments. The vertical 
dashed line represents the time at which allopurinol was added for allopurinol supplemented treatments. 
The non-redox state is shown as solid lines in contrast to the redox state represented by dotted lines. The 
values represent mean and standard errors (P <0.05) 
 
Figure 2.  Relative mRNA expression of hepatic endogenous antioxidants enzyme in broiler chickens. (A, 
B and C)  Increase expression of superoxide dismutase (SOD) 1 through 3 in the CLA+ALLO and 
BRB+ALLO groups relative to control.  (D) Effect of treatments on uncoupling protein (UCP3) expression. 
(E and F) Increase in Glutathione 1(GPX1) and GPX3 expression across treatments. Data expressed as 
mean and standard errors. The data was calculated using the δ-δ Ct method.  GAPDH was used as a 
housekeeping gene to normalize. The asterisk indicate a significant difference from control (P < 0.05). 
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Table 1. Ingredient and percentage composition of diet fed to broilers 
Item 
Ingredient  % Control Diet 
CLA oil 
Diet 
Soybean meal 28.3 28.3 
Corn 66.2 66.2 
Regular oil 2.2 1.1 
CLA N/A 1.1 
Dicalcium phospate 1.7 1.7 
Calcium carbonate 0.8 0.8 
Salt 0.25 0.25 
Nutra blend mixa 0.25 0.25 
Methionine 0.2 0.2 
Monensin 0.1 0.1 
Total %   
M. Energyb (kcal/kg) 3130.5 3130.5 
Protein % 19.5 19.5 
Fat % 4.9 4.9 
Fiber % 2.67 2.67 
Calcium  % 0.78 0.78 
Phosphorous % (total) 0.67 0.67 
Phosphorous % 
(avalaible) 0.44 0.44 
Methionine % 0.48 0.48 
Methionine + Cysteine % 0.82 0.82 
Lysine % 1.04 1.04 
a Nutrablend premix is from Premix NB 3000 used at a rate of five lbs/ton Nutra Blend LLC (Neosho,MO) 
consisted of manganese (4%); zinc (4%); iron (2%); copper, 4.500ppm; iodine, 600ppm; selenium, 60ppm; 
vitamine A, 1.4E10e5 IU/lb; vitamin D3, 5.E5 IU/lb;  vitamin E 3.E3 IU/lb;  vitamin B12, 2mg/lb; 
menadione, 150mg/dl; riboflavin, 1200mg/dl; thiamine, 200mg/dl; D-pantothenic acid, 1200mg/dl; niacin; 
5000mg/dl; vitamin B6 250mg/dl; folic acid 125mg/dl; choline, 700000mg/dl; Biotin 6mg/dl. 
b Metabolisable energy 
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Table 2. Oligonucleotide primers for real-time RT-PCR 
Gene   Forward (5'-3') Reverse (5'-3') Annealing (°C) Accession Number 
GAPDH gagggtagtgaaggctgctg cggatcaaaggtggaagaat 60 NM_204305.1 
GPX1 ggaggctctgcagtaaagga cttcgaggctttggaagatg 60 NM_001277853.2 
GPX3 gagatcctccctgcactgaa cacatcccctttctggaaga 60 NM_001163232.2 
(Cu-Zn)SOD1 tgctggacctcgtttagctt ctcatttcccactgccatct 60 NM_205064.1 
(Mn)SOD2 aatggtgggggtcatatcaa agtcacgtttgatggcttcc 60 NM_204211.1 
(Cu-Zn)SOD3 tgtgatccatgagcaggaag gtttgccagcatttccattt 60 XM_015285700.1 
avUCP gagaaacagagcgggatttg ctcctggctcacggatagag 60 NM_204107.1 
1GPX is Glutathione  
aSOD2 is mitochondrial superoxide dismutase using manganese(Mn) as an electron acceptors 
bSOD 1 and 3 are soluble and extracellular respectively, using Copper-Zinc (Cu-Zn) as electron acceptor 
 
 
Table 3. Plasma  glucose at the beginning and last week of sampling  
Treatment  
  Bleed 1   Bleed 4 
  mM   mM 
CON  11.5±0.45  12.4±0.30 
CLA  12.9±0.45  12.0±0.30 
BRB  12.0±0.45  12.6±0.30 
ALLO  12.80.45±  12.9±0.30 
CLA+ALLO  12.0±0.45  12.7±0.30 
BRB+ALLO   12.2±0.45   12.6±0.30 
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Figure 1. Change in plasma uric acid (mM) over the course of the last four weeks of treatments 
 
Figure 2.  Relative mRNA expression of markers of oxidative stress in liver of chickens 
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Chapter 2 
 
Abstract 
Ceramides have been linked with oxidative stress in humans and dairy cows.  In the poultry 
industry, changes in ceramide overtime and under oxidative stress state if not well known. Two 
compounds, conjugated linoleic acid (CLA) and berberine (BRB) a purified compound from plant 
root extract have been suggested to ameliorate antioxidant activity. A ten week study examined 
the effect of CLA and berberine supplementation on markers of oxidative stress in poultry. Broiler 
chickens (n=60) were equally divided into six groups; a control, a CLA group where half of the 
regular oil used in a standard was substituted for a CLA oil mixture of  cis-9 trans-11 and trans-
10 cis-12 isomers, a berberine group (BRB) consisting of berberine supplementation (200mg/Kg 
feed), an allopurinol (ALLO) group  (25mg/kg body weight), a CLA and allopurinol 
(CLA+ALLO) with the same dose as the CLA and allopurinol groups and a berberine and 
allopurinol group (BRB+ALLO) ( 200mg/Kg feed and 25mg/kg body weight, respectively). The 
allopurinol was added to help induced an oxidative stress state. Body weight, plasma uric acid, 
plasma ceramide C16:0, C18:0, C20:0, C22:0 C24:0, saturated and total ceramides were measured 
in a time dependent manner in control and treatment effect of week 6 using GC/MS. The addition 
of allopurinol (ALLO) to the diet induced an oxidative stress state as measured by a significant 
reduction in plasma uric acid.  There was a negative correlation (r = -0.60) between the increase 
in body weight and the decrease in plasma ceramides (C16:0, C18:0 and C20:0) concentrations in 
control chicks. There was a decrease (P<0.05) in plasma ceramides (C20:0, C22:0 and C24:0) in 
chicks supplemented with allopurinol when compared controls. The addition of allopurinol as a 
mean to induce oxidative stress unwittingly affected the liver, which potentially affected the results 
of plasma ceramide in the oxidative stress state. 
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Introduction 
 
Compared to mammals, birds have a higher metabolism, blood glucose concentrations, 
body temperature as well as doubled folded mitochondria. They also have lower concentrations of 
insulin compared mammals (Witthow et al., 1999 ). Despite an increase in potency of chicken 
insulin compared to porcine (Simon et al., 1974), studies in birds have also revealed that the 
concentration of insulin receptors varies from tissue to tissue with muscle expressing the lowest 
concentration (Simon et al., 1977).  These observations suggest that birds are in a constant state of 
insulin resistance (Simon et al., 1978). Birds, however, do not exhibit the classic symptoms 
associated with hyperglycemia observed in mammals, due to their elevated plasma uric acid 
concentrations, a potent antioxidant (Simoyi et al., 2002). Previous studies in poultry have 
established that allopurinol (an antagonist of xanthine and hypoxanthine in the purine degradation 
pathway) administration induced a redox state with an increase in inflammation associated with 
an increase in ROS (Simoyi et al., 2002) and proinflammatory factors (Settle et al., 2015). The 
severity of the redox state can be potentially adjusted by increasing dosages of allopurinol 
administrated (Simoyi et al., 2002). This supplementation of allopurinol in broiler chickens 
induces an “inflammatory state” without a “specific disease” which effectively creates a model in 
which to study diseases in which inflammation is predominant (e.g. Diabetes, atherosclerosis).  
Ceramides (Cer) are sphingolipids composed of a sphingosine back bone attached to a fatty 
acid, and have long been thought of as inert component waxy lipids (Wertz et al., 1983). The acyl 
moiety attached to the sphingosine back bone can vary in length (16 to 24 carbons), the fatty acid 
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attached is mostly dictated by the ceramide synthase homologues (1-6) involved (Bir). However, 
in recent years, it was discovered that they exert a variety of metabolic effects. Amongst these 
metabolic effects, ceramides represent a reliable biomarker of oxidative stress in mammals 
(Andrieu-Abadie et al., 2001, and Cutler et al., 2002). In humans, Cutler et al. (2002) linked the 
death of motor-neuron in amyotrophic lateral sclerosis (ALS) with an increase in ceramide 
accumulation in the membrane wall, which renders the cell increasingly vulnerable to oxidative 
stress. In dairy cows, Rico et al. (2015) established a relationship between elevated plasma 
ceramides (Cer C20:0 and C24:0) and prolonged insulin resistance in peripartal dairy cows. If left 
unchecked, the ceramides down regulated protein kinase B (Akt), a second messenger in the 
insulin pathway, which placed the cow at increased risk of developing metabolic diseases 
(Summers et al., 1998 and Rico et al., 2015). The measurement of ceramides as an early biomarker 
of oxidative stress could thus be beneficial to the poultry industry.  
As a potential marker of oxidative stress, we measured the changes in plasma ceramides 
after allopurinol administration as well as the ability of two compounds, conjugated linoleic acid 
(CLA) and berberine (BRB), to potentially increase antioxidant (Aox) activity/expression in 
response the induced inflammatory state. Conjugate linoleic acid, a family of 18 carbon 
unsaturated fatty acids, is involved in the neutralization of ROS via the uncoupling of the oxidative 
phosphorylation complex in the ETC by uncoupling protein (UCP) (Echtay et al. 2001, Teulier et al. 
2001). Uncoupling protein is a transmembrane protein located in the inner mitochondrial 
membrane. Studies of UCP have provided a mechanism by which unsaturated fatty acids (C14 to 
C18) enhance their activity and expression.  Overall, UCP raises the proton gradient in the inner 
membranes, which increases the probability of any unpaired electrons to react with a proton, which 
prevents the formation of oxygen radicals (Diano et al. 2012, Berardi et al. 2014).  The second 
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compound, berberine, is an alkaloid compound isolated from plant root extract with exogenous 
Aox activity. This compound possesses several benzene rings, which allows the electron to 
circulate within the conjugated double bonds. In addition to being an exogenous AOx, BRB has 
been proposed to increase endogenous AOx expression and exert anti-inflammatory properties (Li 
et al., 2014).   
  In view of the rapid growth rate of broilers, we hypothesized that (1) ceramide 
concentration should increase in broiler chickens during a production cycle (2) and that the 
addition of allopurinol should further should increase this production. To our knowledge, this the 
first time that specific species of plasma ceramides have been measured in birds. (3) Compounds 
which exhibit antioxidants properties, such as conjugated linoleic acid and berberine, are 
hypothesized to reduce the redox state induced by allopurinol and therefore decrease or lower the 
concentration of ceramides as compared to the allopurinol supplemented group (negative control).  
 
Materials and Methods 
 
All procedures and experiments were approved by West Virginia University’s Institution Animal 
Care and Use Committee (ACUC #15-0301.1).  
Experimental Design 
Sixty mixed sex day old Cobb/Cobb 500 broiler chicks were obtained from Pilgrim’s Pride, 
Moorefield, WV.  Chicks were housed within pens and maintained under a twelve hour light-dark 
cycle with temperature set at 27°C. One week after hatch, chicks were divided into six groups and 
tagged with a leg band. The chicks were maintained on a starter diet for the first four weeks. At 
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week five of the study, the broiler chicks were started on their respective treatments (see Table 1, 
in Dartigue et al (submitted)): a control group, a CLA group in which half of the regular oil used 
in the normal diet was substituted for a mixture of 50/50 cis-9 trans-11 and trans-10 cis-12 isomers 
CLA oil (1.1% CLA oil diet) (Ramiah et al., 2014). Group 3 (BRB) was supplemented with 
berberine (200mg/kg of feed) (Li et al 2014), group 4 (ALLO) the diet was supplemented with 
allopurinol (25mg/kg of body weight) (Klandorf et al., 2001), group 5 (CLA+ALLO) and group 6 
(BRB+ALLO) mimicked the CLA and BRB treatments with the addition of allopurinol (25mg/kg 
of body weight) for the last two weeks of the study. The negative control (ALLO), CLA+ALLO 
and BRB+ALLO were supplemented with allopurinol to help induced a state of oxidative stress 
(Simoyi et al., 2001, and Settle et al., 2012). Berberine (chloride hydrate, purity > 99%) and 
allopurinol were purchased from Sigma-Aldrich (Saint Louis, MO, USA). The CLA was 
purchased commercially (Vitamorph Labs, Highland, IN, USA) as 1200 mg capsules. Food and 
water were provided ad libitum.  
Sampling procedure 
 
   Blood samples were obtained from the brachial wing vein of six birds per pen at week three 
of treatment. Each sample was placed in a heparinized tube and stored on ice. The blood samples 
were centrifuged at 2000rpm for 20minutes at 4°C. Plasma sample was then transferred to micro-
centrifuge tube and stored in a -80° C freezer pending analysis.  
Sample analysis 
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 Plasma free fatty acids concentration was measured using an enzymatic colorimetric 
methods (HR Series NEFA-HR, Wako chemicals USA Inc., Richmond VA). Plasma uric acid 
(PUA) was measured using Infinity™ Uric Acid Liquid Stable Reagent assay from Thermo 
Scientific (Waltham, MA, USA; Klandorf et al., 2001). Ceramide were extracted using a modified 
Bligh and Dyer with a C12:0 Ceramide internal standard (Avanti Polar Lipids, Alabaster, AL). 
Extraction and measurement of ceramide were as described in Rico et al. (2015). Concentrations 
of plasma ceramides C16, 18, 20, 22 and 24 were measured.  
Statistical Analysis 
 
The statistical program SAS (version 9.3; SAS Institute Inc., Cary, NC) was used to 
analyze the data. Both time and treatment effects were analyzed. The time-dependent data were 
studied as repeated measures and run as a mixed model. Weeks were considered as a fixed effect 
whereas birds were treated as random effect.  A generalized linear model was used to study the 
treatment effect at week 10 of the study. The method of Kenward-Roger (1997) was used to 
calculate the degrees of freedom for the denominator. A measure of dependence in both time and 
treatment effects was performed using a Pearson’s contingency coefficient. Values are expressed 
as least square (LSM) ± standard error (SE) unless stated otherwise. Statistical significance was 
set at P < 0.05 and 0.01.   
Results 
 
 There was a significant increase in body weight in controls (BW) over the last four weeks 
of the study (Figure 1, A).  Plasma uric acid concentrations in controls remained constant around 
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0.4mM, although a slight but significant (P = 0.055) increase was noted between weeks 5 and 6 of 
the study (Figure 1, B). In controls, non-esterified free fatty acids stayed leveled around 200 μM 
during weeks 3 to 5 of the study before significantly (P< 0.05) falling to 100 μM (Figure 1. C).  
Plasma ceramides C22 and C24 were observed to have the highest concentrations at ~ 900 
and 1000 ng/ml, respectively (Figure 1, D). These were followed by plasma ceramide C16 with a 
concentration around 200 ng/ml (Figure 1, E). Plasma ceramides C18 and C20 were the least 
expressed with concentrations ranging from 30 to 70 ng/ml (Figure 1, F). The different species of 
plasma ceramide followed the same decreasing trend throughout the 4 weeks (Figure 1). Plasma 
Cer C16, C18, C20, C22, C24, as well as total saturated and total ceramides decreased (P < 0.05) 
between weeks 3 and 5. However, at week 4 Ceramides C20, C22, C24, total saturated and total 
ceramides had significantly increased compared too weeks 3 to 5, restoring approximately 60% of 
the original values (Figure 1, D, F and G). There were no significant changes was observed in 
ceramide C16 and C18 between weeks 5 and 6 (Figure 1, E and F). Notably, Cer C16, C18 and 
C20 concentrations were negatively correlated (r = -0.57) with the increase in BW. 
There were no treatment effects on BW (Figure 2, A), which was comparable to plasma 
Cer C18 concentration albeit, numerical differences were noted in the redox groups (Figure 2, B). 
Non-esterified free fatty acids measurements revealed a significant (P <0.05) increase in 
concentrations in all treatments compared to controls (Figure 2, C). There was a significant 
decrease in the plasma C16 ALLO group while only numerical decreases were noted in the 
CLA+ALLO and BRB+ALLO groups compared to controls. Of note, the CLA+ALLO group was 
significantly higher than the ALLO group (Figure 2, D). Plasma ceramide species C20, C22, C24, 
saturated and total ceramides decreased significantly (P < 0.05) in the allopurinol supplemented 
groups compared to controls (Figure 2, B, E and F).  A positive correlation (r = 0.50) between 
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PUA (Figure 2, G) and plasma ceramides C22, C24 and total ceramides behavior was also 
determined.  
Discussion and Conclusions 
 
Ceramides are sphingolipids that have been positively associated with oxidative stress and 
metabolic diseases in mammals (Andrieu-Abadie et al., 2001, and Cutler et al., 2002) but their role 
in birds has not been established. A redox state in birds can be induced by a variety of factors, 
amongst them allopurinol (Klandorf et al., 2001, Simoyi et al., 2002), with a shift towards 
prooxidants which can be detrimental. Previous research has demonstrated that allopurinol can 
reduce liver uric acid production by inhibiting liver xanthine oxidase (Simoyi et al., 2002, Carro 
et al., 2009, and Settle et al., 2012). The decrease in PUA, a potent antioxidants in birds, can lead 
to state of oxidative stress characterized by overall inflammation but also liver inflammation 
(Carro et al., 2009, Settle et al., 2015). In addition, Carro et al. (2009) determined that various 
doses of allopurinol could change the severity of the redox state, effectively creating a somewhat 
controllable model of oxidative stress. We made use of this model to investigate plasma ceramides 
in broiler chickens. Changes in plasma ceramide concentrations were first determined during the 
growth phase and in response to different treatments.   
 Measurement of plasma ceramides in control birds over the course of 4 weeks revealed an 
overall significant decline in plasma ceramides although between week 5 and 6 some species 
significantly increased (C22:0 and C24:0) whereas others (C16:0, C18:0 and C20:0) remained 
depressed. These results did not support our initial hypothesis, as plasma ceramide concentrations 
increased with age in broiler chicks as has been observed in other species (Lightle et al., 2000). 
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These observations may result from a decrease in the growth rate/metabolic rate observed at 5 
weeks of age in broiler chickens as has been previously described (Kuenzel et al., 1977). Schols 
et al. (1996) suggested that an increase in basal metabolic rate was associated with an increase in 
the inflammatory state in humans as indicated by the increase in inflammatory markers. Hence, 
the downturn in metabolic rate and decrease in oxygen (O2) consumption is suggested to parallel 
the decrease in plasma ceramides concentrations. If the downtrend was prolonged past week 5 of 
age as measured by Kuenzel et al. (1977) this would support the negative correlation (r = -0.57) 
observed between the increase in body weight and the decrease in plasma ceramide concentrations.  
The liver is primary organ for free fatty acid synthesis in birds (Whittow et al., 1999). 
Ceramide synthesis occurs via the addition of a fatty acid moiety to a sphingosine back bone via 
ceramide synthase (Bikman et al., 2011). In this study, non-esterified fatty acids concentrations 
were relatively constant until a significant decline (P < 0.05) was observed between weeks 5 and 
6, with this decrease reciprocally paralleling the increase in plasma ceramides during this same 
period. Watt et al. (2012) demonstrated that ceramide synthesis was dependent on substrate 
availability rather than liver serine palmitoyltransferase (SPT) activity. These results suggest that 
a fraction of avalaible free fatty acids may have been shuttled towards ceramide synthesis, while 
free fatty acids levels were not restored to their original levels. As ceramides are markers of 
oxidative stress and positively correlated with inflammation characterized by ROS production 
(Andrieu-Abadie et al., 2001, Villena et al., 2007), this scenario could also account for the increase 
(P < 0.055) in PUA, a potent antioxidant, during that period.  
The induction of an inflammatory state by allopurinol was evident by the significant 
decreases in plasma uric acid. However, (2) plasma ceramides in the allopurinol fed groups did 
not increase as predicted, rather there was a significant decrease in most species measured. The 
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inflammatory state is associated with an increase in protein synthesis as observed in rats, including 
various inflammatory proteins such as interleukins and their counterparts (anti-inflammatory and 
antioxidants proteins) (Birch et al., 1986, Vary et al., 1992, Knight et al., 2005) . This increase in 
liver protein synthesis coupled with the decrease in feed intake caused by allopurinol may have 
contributed to the decrease in plasma ceramides concentrations. Comparably, serine amino acids, 
which are required for ceramide synthesis, could be redirected towards protein synthesis as well 
(Birch et al., 1986, Vary et al., 1992). Schreiber et al. (1982) demonstrated that a labeled pool of 
liver leucine in rats was incorporated into plasma proteins, for up to 3 days after the challenge as 
result of inducing inflammation.  
NEFA were significantly elevated in all treatments compared to controls. This increase in 
NEFA may be a result of the inclusion of CLA, BRB and allopurinol in the diet. BRB has been 
suggested to inhibit adipogenesis in mammals, (Choi et al., 2006, Hu et al., 2010) which could 
explain the observed increase in NEFA.  Conjugated linoleic acid is known to increase the rate of 
lipolysisin adipose tissues, which would explain the increase in circulating fatty acids 
(REFERENCE). Although similar results were observed in Moulard ducks (hybrid of Muscovy 
and Pekin ducks) (Felser et al., 2013); a decrease in total hepatic NEFA (which would suggest a 
decrease in serum NEFA) was observed in chickens fed CLA (Ko et al., 2004). Previous studies 
in ApoE KO mice supplemented with 10μM of allopurinol for 4 weeks revealed a numerical 
increase in serum NEFA, which was suggested to be the result of allopurinol inhibiting the uptake 
of low density lipoprotein (LDL) into macrophages. In a second study the authors increased the 
expression of xanthine oxidoreductase in cell cultures which increased LDL uptake in macrophage 
cells resulting in foam cell formation (Kushiyama et al., 2012). The combined synergistic effect 
of BRB+ALLO would explain the difference (P = 0.0504) in NEFA observed between the BRB 
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and BRB+ALLO groups. However, only a numerical increase in NEFA was noted in the 
CLA+ALLO group compared to CLA. 
Both plasma ceramide C16 and C18 in controls and treatments were the least changed 
compared to the other ceramides species. There was a significant linear decrease in C16 and C18 
in controls. However, there was a numerical decrease in C16 and C18 concentrations when 
challenged with allopurinol. Ceramides C16 and C18 have been linked to insulin resistance. Turpin 
et al 2014 demonstrated that an increase in Cer C16 further aggravated the insulin resistance state 
in mice. In a study where Ceramide synthase 6 (CerS6) knockout mice were used to investigate 
the absence of Cer C16, the authors observed a decrease in the ceramide C16 coupled with an 
improvement in insulin sensitivity and an increase energy expenditure. If Cer C16:0’s metabolic 
effects were comparable to avian species, the concentrations measured in the present study might 
help to explain why birds are in a constant state of hyperglycemia. In addition, Ceramide synthase 
(CerS) 6 and 5 (producers of Cer C16:0 and C18:0) are equally expressed in a greater number of 
tissues than Cers 2 and 4 (producers of Cer C20:0- C24:0) which are mostly expressed in liver and 
kidneys (Grösch et al., 2011). If this pattern of expression is similar in birds, this might explain 
the decrease in plasma ceramides C20 to C24 in the broiler chickens fed allopurinol. 
Measurement of ceramide in broiler chickens as markers of oxidative stress is feasible as 
they have already been correlated with oxidative stress and ROS production in other species. In 
addition, treatments for some ceramide specific associated diseases have already been devised. In 
human patients with amyotrophic lateral sclerosis (ALS), the authors observed an increase and 
accumulation of Cer C16 in neurons which resulted in the death of the neurons. They also 
demonstrated that treatment with the antibiotic myroicin, an inhibitor of SPT, resulted in a decrease 
in Cer 16 accumulation in cells (Culter et al., 2002). A provisional analysis of ceramides in 
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growing broiler chickens, revealed a deecline towards the end of the growth phase (weeks 2 to ~8 
of age) (Kuenzel et al., 1977). Under conditions of oxidative stress, most species of ceramides are 
decreased, however, this may be an indirect consequence of inducing the inflammatory state. The 
use of allopurinol although practical specifically targets the liver which in birds, is the primary 
organ for fatty acids synthesis. For this reason, ceramide production might have been unwittingly 
affected by the addition of allopurinol. Alternative methods to induce an oxidative stress state 
challenge should be investigated to corroborate the findings of this study. 
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Figure 1. Changes in plasma ceramides, PUA, NEFA and weight in control birds over time 
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Figure 2. Treatment effects on body weight, plasma ceramides, PUA and NEFA 
 
 
Figure 1. Plasma concentrations of (A, B, C, and D) ceramides, (E) NEFA, and (F) plasma uric acid in control broiler 
chickens over-time. Overall for panel A, B, C and D there was a significant decrease in plasma ceramide 
concentrations over the course of the first three weeks (7, 8 and 9) of bleed. In A, there was increase although not 
significant in C16 ceramide compared to the previous week. The same pattern was observed in panel B for C18 
ceramide. In the case of C20 ceramide (also B), there was significant increase from the 9th to the 10th weeks, this 
pattern was also observed in C24 and C22 ceramide (C) and saturated and total ceramides (D). There was decrease in 
NEFA (E) with a significant decrease observed from week 9 to 10. For plasma uric acid, the concentration were pretty 
similar until week 9; between week 9 and 10, there was significant increase.  P < 0.05.  
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Figure 2. Body weight (A), plasma ceramide concentrations of (B,D,E,F) ceramide, (G) uric acid and (B) NEFA, of 
broiler chicken on week 10 of treatment. Panel A represent the body weight, there were no significant changes to 
report.  (B) There were no significicant differences in plasma ceramide 18, in constrast all the groups supplemented 
with ceramide C20:0 were significantly decrease compared to controls. (C)The measurement of NEFA revealed a 
significant increase in all groups compared to control In panel D, there was a significant decrease in C16 ceramide in 
the allopurinol group compared to control and a significant difference between ALLO and the CLA+ALLO group. In 
addition, a numerical decrease in the CLA+ALLO and BRB+ALLO group was noted. Panel E and F followed the 
same pattern, there was a significant decrease in plasma ceramides and plasma uric acid concentrations in the ALLO, 
CLA+ALLO and BRB+ALLO groups compared to control. The notation a represents significance compared to control 
whereas b compares to the ALLO group. P < 0.05    
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